4883.T
Price:
$59
Market Cap:
$4.54B
Modalis Therapeutics Corporation engages in the research and development of therapeutics to treat patients with serious genetic disorders. It is developing therapies for genetic diseases using its proprietary CRISPR-GNDM technology that enables to control gene expressions through modulating the switch (epigenetics of a specific locus. The company has a. joint research agreement with JCR Pharmaceuticals Co., Ltd. to evaluate the drug delivery technology of the gene therapy to the central nervous system (CNS) assuming CNS diseases as a target. The company was formerly known as EdiGENE Corporation and changed its name to Modalis Therapeutics Corporation in August 2019. Modalis Therapeutics Corp...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2020-08-03
Stock Exchange
JPX
Ticker
4883.T
According to Modalis Therapeutics Corporation’s latest financial reports and current stock price. The company's current ROE is -71.83%. This represents a change of 294.63% compared to the average of -18.20% of the last 4 quarters.
The mean historical ROE of Modalis Therapeutics Corporation over the last ten years is -56.61%. The current -71.83% ROE has changed 26.90% with respect to the historical average. Over the past ten years (40 quarters), 4883.T's ROE was at its highest in in the December 2024 quarter at -7.26%. The ROE was at its lowest in in the December 2023 quarter at -58.68%.
Average
-56.61%
Median
-37.14%
Minimum
-173.27%
Maximum
3.64%
Discovering the peaks and valleys of Modalis Therapeutics Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 590.05%
Maximum Annual ROE = 3.64%
Minimum Annual Increase = -298.26%
Minimum Annual ROE = -173.27%
| Year | ROE | Change |
|---|---|---|
| 2025 | -77.07% | 107.48% |
| 2024 | -37.14% | -78.56% |
| 2023 | -173.27% | 88.56% |
| 2022 | -91.89% | 590.05% |
| 2021 | -13.32% | 84.33% |
| 2020 | -7.22% | -298.26% |
The current ROE of Modalis Therapeutics Corporation (4883.T) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-95.83%
5-year avg
-78.54%
10-year avg
-56.61%
Modalis Therapeutics Corporation’s ROE is greater than SymBio Pharmaceuticals Limited (-219.93%), less than Nippon Chemiphar Co., Ltd. (2.86%), greater than Cyfuse Biomedical K.K. (-29.55%), less than WDB coco Co., Ltd. (16.27%), greater than PRISM BioLab Co.,LTD (-33.93%), greater than MedRx Co., Ltd (-48.07%), greater than Solasia Pharma K.K. (-61.70%), less than Shigematsu Works Co., Ltd. (8.01%), greater than Pharmarise Holdings Corporation (-2.10%), greater than D. Western Therapeutics Institute, Inc. (-52.76%),
| Company | ROE | Market cap |
|---|---|---|
| -219.93% | $5.90B | |
| 2.86% | $6.41B | |
| -29.55% | $5.40B | |
| 16.27% | $6.50B | |
| -33.93% | $7.12B | |
| -48.07% | $6.35B | |
| -61.70% | $8.95B | |
| 8.01% | $7.74B | |
| -2.10% | $5.87B | |
| -52.76% | $4.38B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Modalis Therapeutics Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Modalis Therapeutics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Modalis Therapeutics Corporation's ROE?
How is the ROE calculated for Modalis Therapeutics Corporation (4883.T)?
What is the highest ROE for Modalis Therapeutics Corporation (4883.T)?
What is the 3-year average ROE for Modalis Therapeutics Corporation (4883.T)?
What is the 5-year average ROE for Modalis Therapeutics Corporation (4883.T)?
How does the current ROE for Modalis Therapeutics Corporation (4883.T) compare to its historical average?